143 related articles for article (PubMed ID: 15835918)
1. Tandem mass spectrometry for the examination of the posttranslational modifications of high-mobility group A1 proteins: symmetric and asymmetric dimethylation of Arg25 in HMGA1a protein.
Zou Y; Wang Y
Biochemistry; 2005 Apr; 44(16):6293-301. PubMed ID: 15835918
[TBL] [Abstract][Full Text] [Related]
2. Acetylation and phosphorylation of high-mobility group A1 proteins in PC-3 human tumor cells.
Jiang X; Wang Y
Biochemistry; 2006 Jun; 45(23):7194-201. PubMed ID: 16752910
[TBL] [Abstract][Full Text] [Related]
3. Mass spectrometric analysis of high-mobility group proteins and their post-translational modifications in normal and cancerous human breast tissues.
Zou Y; Wang Y
J Proteome Res; 2007 Jun; 6(6):2304-14. PubMed ID: 17455969
[TBL] [Abstract][Full Text] [Related]
4. In vivo posttranslational modifications of the high mobility group A1a proteins in breast cancer cells of differing metastatic potential.
Edberg DD; Bruce JE; Siems WF; Reeves R
Biochemistry; 2004 Sep; 43(36):11500-15. PubMed ID: 15350136
[TBL] [Abstract][Full Text] [Related]
5. A mass spectrometric study on the in vitro methylation of HMGA1a and HMGA1b proteins by PRMTs: methylation specificity, the effect of binding to AT-rich duplex DNA, and the effect of C-terminal phosphorylation.
Zou Y; Webb K; Perna AD; Zhang Q; Clarke S; Wang Y
Biochemistry; 2007 Jul; 46(26):7896-906. PubMed ID: 17550233
[TBL] [Abstract][Full Text] [Related]
6. During apoptosis of tumor cells HMGA1a protein undergoes methylation: identification of the modification site by mass spectrometry.
Sgarra R; Diana F; Bellarosa C; Dekleva V; Rustighi A; Toller M; Manfioletti G; Giancotti V
Biochemistry; 2003 Apr; 42(12):3575-85. PubMed ID: 12653562
[TBL] [Abstract][Full Text] [Related]
7. A quantitative study on the in vitro and in vivo acetylation of high mobility group A1 proteins.
Zhang Q; Zhang K; Zou Y; Perna A; Wang Y
J Am Soc Mass Spectrom; 2007 Sep; 18(9):1569-78. PubMed ID: 17627840
[TBL] [Abstract][Full Text] [Related]
8. Macroscopic differences in HMGA oncoproteins post-translational modifications: C-terminal phosphorylation of HMGA2 affects its DNA binding properties.
Sgarra R; Maurizio E; Zammitti S; Lo Sardo A; Giancotti V; Manfioletti G
J Proteome Res; 2009 Jun; 8(6):2978-89. PubMed ID: 19317492
[TBL] [Abstract][Full Text] [Related]
9. Dynamic and differential in vivo modifications of the isoform HMGA1a and HMGA1b chromatin proteins.
Edberg DD; Adkins JN; Springer DL; Reeves R
J Biol Chem; 2005 Mar; 280(10):8961-73. PubMed ID: 15591590
[TBL] [Abstract][Full Text] [Related]
10. Phosphorylation of human high mobility group N1 protein by protein kinase CK2.
Jiang XG; Wang Y
Biochem Biophys Res Commun; 2006 Jul; 345(4):1497-503. PubMed ID: 16729963
[TBL] [Abstract][Full Text] [Related]
11. Homeodomain-interacting protein kinase-2 (HIPK2) phosphorylates HMGA1a at Ser-35, Thr-52, and Thr-77 and modulates its DNA binding affinity.
Zhang Q; Wang Y
J Proteome Res; 2007 Dec; 6(12):4711-9. PubMed ID: 17960875
[TBL] [Abstract][Full Text] [Related]
12. The relative influence of phosphorylation and methylation on responsiveness of peptides to MALDI and ESI mass spectrometry.
Gropengiesser J; Varadarajan BT; Stephanowitz H; Krause E
J Mass Spectrom; 2009 May; 44(5):821-31. PubMed ID: 19301359
[TBL] [Abstract][Full Text] [Related]
13. Determination of the post-translational modifications of salivary acidic proline-rich proteins.
Castagnola M; Cabras T; Inzitari R; Zuppi C; Rossetti DV; Petruzzelli R; Vitali A; Loy F; Conti G; Fadda MB
Eur J Morphol; 2003 Apr; 41(2):93-8. PubMed ID: 15621862
[TBL] [Abstract][Full Text] [Related]
14. Mass spectrometric analysis of histone posttranslational modifications.
Burlingame AL; Zhang X; Chalkley RJ
Methods; 2005 Aug; 36(4):383-94. PubMed ID: 16112065
[TBL] [Abstract][Full Text] [Related]
15. Collective mass spectrometry approaches reveal broad and combinatorial modification of high mobility group protein A1a.
Young NL; Plazas-Mayorca MD; DiMaggio PA; Flaniken IZ; Beltran AJ; Mishra N; LeRoy G; Floudas CA; Garcia BA
J Am Soc Mass Spectrom; 2010 Jun; 21(6):960-70. PubMed ID: 20202861
[TBL] [Abstract][Full Text] [Related]
16. Proteomics study reveals cross-talk between Rho guanidine nucleotide dissociation inhibitor 1 post-translational modifications in epidermal growth factor stimulated fibroblasts.
Guerrera IC; Keep NH; Godovac-Zimmermann J
J Proteome Res; 2007 Jul; 6(7):2623-30. PubMed ID: 17506542
[TBL] [Abstract][Full Text] [Related]
17. Protein posttranslational modifications: phosphorylation site analysis using mass spectrometry.
Annan RS; Zappacosta F
Methods Biochem Anal; 2005; 45():85-106. PubMed ID: 19235292
[No Abstract] [Full Text] [Related]
18. Identification of endogenous phosphorylation sites of bovine medium and low molecular weight neurofilament proteins by tandem mass spectrometry.
Trimpin S; Mixon AE; Stapels MD; Kim MY; Spencer PS; Deinzer ML
Biochemistry; 2004 Feb; 43(7):2091-105. PubMed ID: 14967049
[TBL] [Abstract][Full Text] [Related]
19. Protein pI shifts due to posttranslational modifications in the separation and characterization of proteins.
Zhu K; Zhao J; Lubman DM; Miller FR; Barder TJ
Anal Chem; 2005 May; 77(9):2745-55. PubMed ID: 15859589
[TBL] [Abstract][Full Text] [Related]
20. A mass spectrometry based method for distinguishing between symmetrically and asymmetrically dimethylated arginine residues.
Brame CJ; Moran MF; McBroom-Cerajewski LD
Rapid Commun Mass Spectrom; 2004; 18(8):877-81. PubMed ID: 15095356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
